Clinical trials: Cancer Uterus Cervix
Endometrial Cancer, Cervix Cancer
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Cervical cancer is the 4th most common cancer in women globally and the 2nd most common in India. In India, between 2018 and 2020, cervical cancer saw a surge of 26,985 from 2018 to 2020.
- Trial name
- NCT07435623
- Where
- India
- Volunteers
- 300 people
- Sponsor
- Tata Memorial Hospital
Cervix Neoplasms, Ovarian Neoplasms
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
The purpose of the study is to determine the diagnostic accuracy of a new magnetic resonance imaging (MRI) technique, the diffusion weighted imaging with body background signal suppression (DWIBS) in the detection of lymph node…
- Conditions
- Cervix Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Vulvar Neoplasms
- Trial name
- NCT00288821
- Where
- Netherlands
- Volunteers
- 84 people
- Sponsor
- UMC Utrecht
Dysplasia, Cervix
Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia
To evaluate the effectiveness of virtual reality glasses as a distraction technique in the management of acute pain and anxiety during conization of cervix uterus under local anesthesia
- Trial name
- NCT04742543
- Testing
- SootheVR: AppliedVR, Los Angeles, California a head-mounted display
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
Papillomavirus Infections
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
This project will compare the rate of regression of minimally abnormal Pap smears to normal in women who receive Gardasil to a historical control group.
- Trial name
- NCT00501189
- Testing
- human papillomavirus vaccine L1, type 6,11,16,18
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Eisenhower Army Medical Center
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or…
- Trial name
- NCT02689726
- Testing
- GTL001+, Aldara
- Where
- 4 sites in United States
- Volunteers
- 13 people
- Sponsor
- Genticel
Uterine Cervical Neoplasms
Imaging the Uterine Cervix - UltraSightHD™
The purpose of this study is to investigate the performance ability of the UltraSightHD™. The instrument will be assessed on characteristics such as focus quality, ability to image the entire cervix, and illumination.
- Trial name
- NCT01090635
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- STI-Medical Systems
Cervical Cancer, Uterine Cancer
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Objectives: Primary: To estimate the efficacy of bevacizumab and paclitaxel in patients with recurrent small cell, large cell, and neuroendocrine cervical and uterine cancers, as measured by progression-free survival.
- Trial name
- NCT00626561
- Testing
- Bevacizumab, Paclitaxel
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- M.D. Anderson Cancer Center
Cervical Dysplasia, Cervical Disease
Colposcopy and Dynamic Spectral Imaging (DSI)
This study evaluates the Dynamic Spectral Imaging (DSI) Colposcope (DySIS) in it's ability to diagnose cervical dysplasia. Half of participants with be examined by the DySIS colposcope, there the other half will be examined by…
- Conditions
- Cervical Dysplasia, Cervical Disease, Cervical Lesion, Cervix Cancer
- Trial name
- NCT04249856
- Testing
- Dynamic Spectral Imaging (DYSIS)
- Where
- 4 sites in Denmark
- Volunteers
- 3,000 people
- Sponsor
- University of Aarhus
Malignant Head and Neck Neoplasm, Malignant Neoplasm
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and…
- Conditions
- Malignant Head and Neck Neoplasm, Malignant Neoplasm, Metastatic Malignant Neoplasm in the Neck, Metastatic Malignant Neoplasm in the Uterine Cervix
- Trial name
- NCT01365169
- Testing
- Exercise Intervention, Health Telemonitoring, Quality-of-Life Assessment
- Where
- United States
- Volunteers
- 590 people
- Sponsor
- M.D. Anderson Cancer Center
Cervical Cancer
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
- Trial name
- NCT00057928
- Testing
- cisplatin, gemcitabine hydrochloride, paclitaxel
- Where
- 106 sites in United States, Canada
- Sponsor
- SWOG Cancer Research Network
Postsurgery Recurrent Carcinoma Cervix
Tomotherapy in Postsurgery Recurrent Carcinoma Cervix
Radiotherapy is the most appropriate treatment for postoperative recurrent carcinoma cervix. However it is technically difficult to deliver adequate doses of RT due to presence of small intestines in the radiation area; thus…
- Trial name
- NCT01117402
- Testing
- Radiotherapy
- Where
- India
- Volunteers
- 90 people
- Sponsor
- Tata Memorial Hospital
Cervix Neoplasms, Uterine Neoplasms
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
The primary goal of this pilot study is to assess the feasibility of using magnetic resonance (MR) imaging guidance in the Magnetic Resonance Therapy (MRT) unit at the Brigham and Women's Hospital during the implantation of…
- Conditions
- Cervix Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms
- Trial name
- NCT00112307
- Testing
- Brachytherapy
- Volunteers
- 15 people
- Sponsor
- Brigham and Women's Hospital
Colorectal Cancer, Breast Cancer
Effectiveness of Care in Certified Cancer Centres in Germany
Assessment of the effectiveness of care in certified cancer centres for eight cancer entities via a retrospective cohort study based on secondary data from statutory health insurance funds and population-based clinical cancer…
- Conditions
- Colorectal Cancer, Breast Cancer, Ovarian Cancer, Cervix Cancer
- Trial name
- WiZen (NCT04334239)
- Testing
- Oncological certification
- Where
- Germany
- Volunteers
- 670,000 people
- Sponsor
- Technische Universität Dresden
Carcinomas, Cervix Cancer
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
This is a Phase 2, single center, open-label, single-arm study designed to evaluate the efficacy, safety, tolerability, and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic…
- Conditions
- Carcinomas, Cervix Cancer, Cervical Cancer
- Trial name
- NCT05063916
- Testing
- AK104
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- M.D. Anderson Cancer Center
Cervical Neoplasia
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Background: In most women, HPV infection does not cause symptoms and the infection goes away on its own. In a small percentage of women, the HPV infection does not go away and sometimes can result in cervical precancer or cancer.
- Trial name
- NCT00435214
- Where
- United States
- Volunteers
- 131,110 people
- Sponsor
- National Cancer Institute (NCI)
Cervix Cancer, Oncology
Study of a Predictor for Cervix Cancer
Non operated cervix cancer are usually treated by radio-chemotherapy. Non control local rate is inexplicably close to 30%. However, important volume of those tumors and their hypoxia degree induce phenomenon of pathologic…
- Trial name
- ANOXICOL (NCT01641484)
- Testing
- local control at 19.8Gy
- Where
- France
- Volunteers
- 9 people
- Sponsor
- Centre Oscar Lambret
Cervical Cancer
Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy
Perspectives: To set-up another clinical trial with this specific phenotype as the main stratification factor. Therefore a more aggressive or a more specific systemic treatment (with or without an immunomodulator) could be…
- Trial name
- IMMUVIX (NCT03255252)
- Testing
- Cisplatin injection, radiotherapy
- Where
- 3 sites in France
- Volunteers
- 29 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
Cervix Cancer
Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features
HPV is known to be the causal agent in the majority of cervical cancers. However, the role of the cervical bacterial microbiome in cervical cancer is not clear
- Trial name
- NCT03959410
- Testing
- Cervical biopsy
- Where
- Italy
- Volunteers
- 150 people
- Sponsor
- University of Campania Luigi Vanvitelli
HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
This study evaluates the use of ABI-1968, a topical cream, in the treatment of cervical precancerous lesions in females without human immunodeficiency virus (HIV) infection.
- Conditions
- HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions, High-Grade Cervical Intraepithelial Neoplasia, Human Papilloma Virus
- Trial name
- NCT03697226
- Testing
- Topical ABI-1968
- Where
- South Africa
- Volunteers
- 8 people
- Sponsor
- Antiva Biosciences
Cervical Cancer
Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix
The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma
- Trial name
- NCT00204997
- Testing
- Laparoscopic ovarian transposition
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Wisconsin, Madison